|
1
|
Cercós P, Peraza DA, de Benito-Bueno A, Socuéllamos PG, Aziz-Nignan A, Arrechaga-Estévez D, Beato E, Peña-Acevedo E, Albert A, González-Vera JA, Rodríguez Y, Martín-Martínez M, Valenzuela C, Gutiérrez-Rodríguez M. Pharmacological Approaches for the Modulation of the Potassium Channel K V4.x and KChIPs. Int J Mol Sci 2021; 22:ijms22031419. [PMID: 33572566 PMCID: PMC7866805 DOI: 10.3390/ijms22031419] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2021] [Revised: 01/27/2021] [Accepted: 01/28/2021] [Indexed: 02/06/2023] Open
Abstract
Ion channels are macromolecular complexes present in the plasma membrane and intracellular organelles of cells. Dysfunction of ion channels results in a group of disorders named channelopathies, which represent an extraordinary challenge for study and treatment. In this review, we will focus on voltage-gated potassium channels (KV), specifically on the KV4-family. The activation of these channels generates outward currents operating at subthreshold membrane potentials as recorded from myocardial cells (ITO, transient outward current) and from the somata of hippocampal neurons (ISA). In the heart, KV4 dysfunctions are related to Brugada syndrome, atrial fibrillation, hypertrophy, and heart failure. In hippocampus, KV4.x channelopathies are linked to schizophrenia, epilepsy, and Alzheimer's disease. KV4.x channels need to assemble with other accessory subunits (β) to fully reproduce the ITO and ISA currents. β Subunits affect channel gating and/or the traffic to the plasma membrane, and their dysfunctions may influence channel pharmacology. Among KV4 regulatory subunits, this review aims to analyze the KV4/KChIPs interaction and the effect of small molecule KChIP ligands in the A-type currents generated by the modulation of the KV4/KChIP channel complex. Knowledge gained from structural and functional studies using activators or inhibitors of the potassium current mediated by KV4/KChIPs will better help understand the underlying mechanism involving KV4-mediated-channelopathies, establishing the foundations for drug discovery, and hence their treatments.
Collapse
Affiliation(s)
- Pilar Cercós
- Instituto de Química Médica (IQM-CSIC), 28006 Madrid, Spain; (P.C.); (M.M.-M.)
| | - Diego A. Peraza
- Instituto de Investigaciones Biomédicas Alberto Sols (IIBM), CSIC-UAM, 28029 Madrid, Spain; (D.A.P.); (A.d.B.-B.); (P.G.S.)
- Spanish Network for Biomedical Research in Cardiovascular Research (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Angela de Benito-Bueno
- Instituto de Investigaciones Biomédicas Alberto Sols (IIBM), CSIC-UAM, 28029 Madrid, Spain; (D.A.P.); (A.d.B.-B.); (P.G.S.)
- Spanish Network for Biomedical Research in Cardiovascular Research (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Paula G. Socuéllamos
- Instituto de Investigaciones Biomédicas Alberto Sols (IIBM), CSIC-UAM, 28029 Madrid, Spain; (D.A.P.); (A.d.B.-B.); (P.G.S.)
- Spanish Network for Biomedical Research in Cardiovascular Research (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Abdoul Aziz-Nignan
- Department of Natural Sciences, Hostos Community College of CUNY, New York, NY 10451, USA; (A.A.-N.); (D.A.-E.); (E.B.); (E.P.-A.); (Y.R.)
| | - Dariel Arrechaga-Estévez
- Department of Natural Sciences, Hostos Community College of CUNY, New York, NY 10451, USA; (A.A.-N.); (D.A.-E.); (E.B.); (E.P.-A.); (Y.R.)
| | - Escarle Beato
- Department of Natural Sciences, Hostos Community College of CUNY, New York, NY 10451, USA; (A.A.-N.); (D.A.-E.); (E.B.); (E.P.-A.); (Y.R.)
| | - Emilio Peña-Acevedo
- Department of Natural Sciences, Hostos Community College of CUNY, New York, NY 10451, USA; (A.A.-N.); (D.A.-E.); (E.B.); (E.P.-A.); (Y.R.)
| | - Armando Albert
- Instituto de Química Física Rocasolano (IQFR-CSIC), 28006 Madrid, Spain;
| | - Juan A. González-Vera
- Departamento de Físicoquímica, Facultad de Farmacia, Universidad de Granada, 18071 Granada, Spain;
| | - Yoel Rodríguez
- Department of Natural Sciences, Hostos Community College of CUNY, New York, NY 10451, USA; (A.A.-N.); (D.A.-E.); (E.B.); (E.P.-A.); (Y.R.)
| | | | - Carmen Valenzuela
- Instituto de Investigaciones Biomédicas Alberto Sols (IIBM), CSIC-UAM, 28029 Madrid, Spain; (D.A.P.); (A.d.B.-B.); (P.G.S.)
- Spanish Network for Biomedical Research in Cardiovascular Research (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain
- Correspondence: ; (C.V.); (M.G.-R.); Tel.: +34-91-585-4493 (C.V.); +34-91-258-7493 (M.-G.R.)
| | - Marta Gutiérrez-Rodríguez
- Instituto de Química Médica (IQM-CSIC), 28006 Madrid, Spain; (P.C.); (M.M.-M.)
- Correspondence: ; (C.V.); (M.G.-R.); Tel.: +34-91-585-4493 (C.V.); +34-91-258-7493 (M.-G.R.)
| |
Collapse
|